Style | Citing Format |
---|---|
MLA | Meidani M, et al.. "Aspergillus Spondylodiscitis in an Immunocompetent Patient With Recurrent Aspergillus Endocarditis; a Clinical Case Report." Open Forum Infectious Diseases, vol. 12, no. 4, 2025, pp. -. |
APA | Meidani M, Moradi M, Rahmanian M, Salehi M, Foroumandi M, Larti F, Alijani N, Movahhed H, Rahimi E, Ghiasvand F (2025). Aspergillus Spondylodiscitis in an Immunocompetent Patient With Recurrent Aspergillus Endocarditis; a Clinical Case Report. Open Forum Infectious Diseases, 12(4), -. |
Chicago | Meidani M, Moradi M, Rahmanian M, Salehi M, Foroumandi M, Larti F, Alijani N, Movahhed H, Rahimi E, Ghiasvand F. "Aspergillus Spondylodiscitis in an Immunocompetent Patient With Recurrent Aspergillus Endocarditis; a Clinical Case Report." Open Forum Infectious Diseases 12, no. 4 (2025): -. |
Harvard | Meidani M et al. (2025) 'Aspergillus Spondylodiscitis in an Immunocompetent Patient With Recurrent Aspergillus Endocarditis; a Clinical Case Report', Open Forum Infectious Diseases, 12(4), pp. -. |
Vancouver | Meidani M, Moradi M, Rahmanian M, Salehi M, Foroumandi M, Larti F, et al.. Aspergillus Spondylodiscitis in an Immunocompetent Patient With Recurrent Aspergillus Endocarditis; a Clinical Case Report. Open Forum Infectious Diseases. 2025;12(4):-. |
BibTex | @article{ author = {Meidani M and Moradi M and Rahmanian M and Salehi M and Foroumandi M and Larti F and Alijani N and Movahhed H and Rahimi E and Ghiasvand F}, title = {Aspergillus Spondylodiscitis in an Immunocompetent Patient With Recurrent Aspergillus Endocarditis; a Clinical Case Report}, journal = {Open Forum Infectious Diseases}, volume = {12}, number = {4}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - Meidani M AU - Moradi M AU - Rahmanian M AU - Salehi M AU - Foroumandi M AU - Larti F AU - Alijani N AU - Movahhed H AU - Rahimi E AU - Ghiasvand F TI - Aspergillus Spondylodiscitis in an Immunocompetent Patient With Recurrent Aspergillus Endocarditis; a Clinical Case Report JO - Open Forum Infectious Diseases VL - 12 IS - 4 SP - EP - PY - 2025 ER - |